Table 3.

Procedural Characteristics

n=65
No. of implanted BVS per patient, n1.8±0.7
 Patient treated with 1 BVS, n (%)24 (36.9)
 Patient treated with 2 BVSs, n (%)31 (47.7)
 Patient treated with ≥3 BVSs, n (%)10 (15.4)
BVS diameter per stent, mm3.0±0.4
BVS total length per patient, mm47.6±19.9
Predilatation balloon diameter, mm2.6±0.5
Rotational atherectomy, n3 (4.6)
Postdilatation balloon diameter, mm3.3±0.3
Max pressure for postdilatation, atm18.6±5.3
IVUS, n (%)34 (52.3)
OCT, n (%)31 (47.7)
Antegrade approach, n (%)53 (81.5)
Retrograde approach, n (%)12 (18.5)
Double injection, n (%)51 (78.5)
DES implantation in non-CTO lesions, n (%)17 (26.2)
Complete revascularization, n (%)52 (80.0)
  • Values are n (%) or mean±SD. BVS indicates bioresorbable vascular scaffold; CTO, chronic total occlusion; DES, drug-eluting stent; IVUS, intravascular ultrasound; and OCT, optical coherence tomography.